Empowering consumers, patients and pharmacists – April 9, 2019
Government action on drug pricing has had unintended consequences for community pharmacies and healthcare Avricore Health’s offering helps pharmacists grow revenues, enhance role in customer care HealthTab™ allows quick access to health biomarkers, personalized genomic information The Government of Canada’s recent actions to take costs out of the health care system have landed squarely on […]
Avricore Health Inc. Advisory Board Welcomes Mark Zhou, March 20, 2019
Avricore Health Inc. Advisory Board Welcomes Mark Zhou Pharmacy practice specialist and McKesson representative brings talent and expertise to Avricore’s strategic development and client education team Vancouver, March 18, 2019 (GLOBE NEWSWIRE) — Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) is very pleased to announce that Mark Zhou will join the company’s Advisory Board and […]
Avricore Health Inc. Closes Non-Brokered Private Placement – March 15, 2019
March 15, 2019 – Avricore Health Inc. (“AVCR”), is pleased to announce that further to its news release dated February 13, 2019, it has closed a non-brokered private placement of 4,206,435 common shares (“Common Shares”) of the Company at a price of $0.07 per Common Share for gross proceeds of approximately CDN$294,451 (the “Offering”). The […]
Avricore Health Announces Issuance of Shares for Services Rendered Vancouver, March 5, 2019
Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) announces that it has issued a total of 125,081 common shares of the Company to Lampyon Canada Inc., in consideration for services rendered pursuant to the terms of a Service Agreement entered into with Avricore Health on April 10th, 2018, and amended on September 19th, 2019. The common […]
Avricore Health Inc. Announces Non-Brokered Private Placement – February 13, 2019
Avricore Health Inc. (“AVCR”), announced today a non-brokered private placement of up to 14,285,714 common shares at a price of $0.07 per common share for gross proceeds of up to $1,000,000 (the “Offering”). The Company may pay a finder’s fee on the Offering within the amount permitted by the policies of the TSX Venture Exchange […]
Avricore Health Provides Update and Outlook for 2019 – February 6, 2019
Avricore Health Inc. (TSX-V: AVCR) (OTCQB: AVCRF) (“Avricore Health” or the “Company”) Dear Shareholders: Thank you for your continued support of Avricore Health. We know this market has been challenging for our industry and our shareholders alike; however, we have had an exciting year and are poised for success in 2019 and beyond. Going forward, […]
Avricore Health Inc. Advisory Board Welcomes Hector Bremner – January 30, 2019
Avricore Health Inc. Advisory Board Welcomes Hector Bremner Communications professional and former advisor to BC Deputy Premier and Vancouver City Councillor will support Strategic and Government Affairs Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) is very pleased to announce that Hector Bremner will join the company’s Advisor Board and support strategic communications and government affairs. […]
Avricore Health Inc. Advisory Board Welcomes Ray Chepesiuk – January 29, 2019
Former Commissioner with the Pharmaceutical Advertising Advisory Board (PAAB) will support strategic marketing practices and ensure strategic direction and regulatory practices. Vancouver, BC / TheNewswire / January 29, 2019 – Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) is very pleased to announce that Ray Chepesiuk will join the company’s Advisory Board and support marketing and […]
Avricore Health Signs Letter of Intent with Molecular You to Further Enhance the HealthTab Platform – December 18, 2018
VANCOUVER, BC, December 18, 2018 – Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) is pleased to announce that it has signed a Letter of Intent (LOI) with Molecular You Corporation (“Molecular You”) to distribute Molecular You’s pharmacogenomic tests designed to ensure safe and effective use of cannabis by customers in a community pharmacy setting. Avricore […]
Avricore Health Signs Letter of Intent to Partner with FoodRocket to Enhance the HealthTab Platform – November 27, 2018
VANCOUVER, BC, November 27, 2018 – Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) is pleased to announce that it has signed a letter of intent to review opportunities to collaborate with FoodRocket to integrate FoodRocket’s precision health offerings and genomics with the HealthTab platform across Canada. Avricore Health is actively pursuing the expansion of its […]
